Zobrazeno 1 - 10
of 11
pro vyhledávání: '"M R, Sydes"'
Autor:
E. J. Mitchell, D. Appelbe, A. Bravery, L. Culliford, H. Evans, A. J. Farrin, K. Gillies, K. Hood, S. B. Love, M. R. Sydes, P. R. Williamson, N. Wakefield, as part of the e-Consent collaborative group
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-11 (2023)
Abstract Background During the COVID-19 pandemic, in-person healthcare visits were reduced. Consequently, trial teams needed to consider implementing remote methods for conducting clinical trials, including e-Consent. Although some clinical trials ma
Externí odkaz:
https://doaj.org/article/7f9bf77b915a4f9093527f42f6488f88
Autor:
K. D. Coulman, A. Nicholson, A. Shaw, A. Daykin, L. E. Selman, R. Macefield, G. W. Shorter, H. Cramer, M. R. Sydes, C. Gamble, M. E. Pick, G. Taylor, J. A. Lane
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-15 (2020)
Abstract Background Trial oversight is important for trial governance and conduct. Patients and/or lay members of the public are increasingly included in trial oversight committees, influenced by international patient and public involvement (PPI) ini
Externí odkaz:
https://doaj.org/article/1558cf34fd294a508406c16eaa30eacb
Autor:
C C, Parker, N W, Clarke, C, Catton, H, Kynaston, A, Cook, W, Cross, C, Davidson, C, Goldstein, J, Logue, C, Maniatis, P M, Petersen, P, Neville, H, Payne, R, Persad, C, Pugh, A, Stirling, F, Saad, W R, Parulekar, M K B, Parmar, M R, Sydes
Publikováno v:
Clinical Oncology. 34:593-597
Publikováno v:
International Journal of Population Data Science
International Journal of Population Data Science, Vol 5, Iss 2 (2020)
International Journal of Population Data Science, Vol 5, Iss 2 (2020)
The international research community is mobilising an unprecedented response to COVID-19, including more than 2500 registered clinical trials [1, 2]. There are also at least 100 observational studies based on administrative and routinely collected he
Autor:
Coulman, K. D., A. Nicholson, A. Shaw, A. Daykin, L. E. Selman, R. Macefield, G. W. Shorter, H. Cramer, M. R. Sydes, C. Gamble, M. E. Pick, G. Taylor, J. A. Lane
Additional file 2: Supplementary table 2. Gripp-2 short form checklist.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18658c195d0c59f7851a1e7b489d5375
Autor:
Coulman, K. D., A. Nicholson, A. Shaw, A. Daykin, L. E. Selman, R. Macefield, G. W. Shorter, H. Cramer, M. R. Sydes, C. Gamble, M. E. Pick, G. Taylor, J. A. Lane
Additional file 1: Supplementary table 1. Standards for Reporting Qualitative Research (SPQR) Checklist.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c2810259efce5754befe56ae402e763
Autor:
C L, Vale, D J, Fisher, I R, White, J R, Carpenter, S, Burdett, N W, Clarke, K, Fizazi, G, Gravis, N D, James, M D, Mason, M K B, Parmar, L H, Rydzewska, C J, Sweeney, M R, Spears, M R, Sydes, J F, Tierney
Publikováno v:
Annals of Oncology
Background Our prior Systemic Treatment Options for Cancer of the Prostate systematic reviews showed improved survival for men with metastatic hormone-naive prostate cancer when abiraterone acetate plus prednisolone/prednisone (AAP) or docetaxel (Doc
Publikováno v:
BMC Medicine
Background Individual participant data (IPD) from completed clinical trials should be responsibly shared to support efficient clinical research, generate new knowledge and bring benefit to patients. The Medical Research Council (MRC) Hubs for Trials
Publikováno v:
Journal of Vascular Surgery. 41(4):602-609
Objective To assess whether a pragmatic policy of perioperative β-blockade, with metoprolol, reduced the 30-day cardiovascular morbidity and mortality and reduced the length of hospital stay in average patients undergoing infrarenal vascular surgery
Autor:
G M, Mead, M R, Sydes, J, Walewski, A, Grigg, C S, Hatton, N, Pescosta, C, Guarnaccia, M S, Lewis, J, McKendrick, S P, Stenning, D, Wright, P, Norbert
Publikováno v:
Annals of Oncology. 13:1264-1274
Background Burkitt's lymphoma (BL) is a rare and rapidly progressive form of B-cell non-Hodgkin's lymphoma. Cyclophosphamide, vincristine, doxorubicin, high-dose methotrexate (CODOX-M)/ifosfamide, etoposide and high-dose cytarabine (IVAC) is a highly